LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples

Elizabeth C Stahl,Allan R Gopez,Connor A Tsuchida,Vinson B Fan,Erica A Moehle,Lea B Witkowsky,Jennifer R Hamilton,Enrique Lin-Shiao,Matthew McElroy,Shana L McDevitt,Alison Ciling,C Kimberly Tsui,Kathleen Pestal,Holly K Gildea,Amanda Keller,Iman A Sylvain,Clara Williams,Ariana Hirsh,Alexander J Ehrenberg,Rose Kantor,Matthew Metzger,Kara L Nelson,Fyodor D Urnov,Bradley R Ringeisen,Petros Giannikopoulos,Jennifer A Doudna,IGI Testing Consortium
DOI: https://doi.org/10.1371/journal.pone.0258263
IF: 3.7
2021-11-10
PLoS ONE
Abstract:Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2-3 separate reactions or rely on detection of a single viral target, which adds significant time, cost, and risk of false-negative results. Furthermore, multiplexed RT-qPCR tests that detect at least two SARS-CoV-2 genes in a single reaction are typically not affordable for large scale clinical surveillance or adaptable to multiple PCR machines and plate layouts. We developed a RT-qPCR assay using the Luna Probe Universal One-Step RT-qPCR master mix with publicly available primers and probes to detect SARS-CoV-2 N gene, E gene, and human RNase P (LuNER) to address these shortcomings and meet the testing demands of a university campus and the local community. This cost-effective test is compatible with BioRad or Applied Biosystems qPCR machines, in 96 and 384-well formats, with or without sample pooling, and has a detection sensitivity suitable for both clinical reporting and wastewater surveillance efforts.
What problem does this paper attempt to address?